Ovarian estradiol production in vivo inhibitory: Effect of leuprolide acetate

Ania Kowalik, Larry Barmat, Mark Damario, Hung Ching Liu, Owen Davis, Zev Rosenwaks

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

OBJECTIVE: To determine the impact of reducing the dose of gonadotropin- releasing hormone agonist (GnRH-a) for controlled ovarian stimulation in vitro fertilization (IVF) on subsequent response to stimulation and cycle outcome. STUDY DESIGN: An IVF database was searched to identify patients who underwent at least two cycles of ovarian stimulation at a university-based medical center, and a retrospective chart review was performed. Fifty-one patients whose IVF stimulation protocols during the two cycles were identical except for the leuprolide dosage utilized for luteal pituitary suppression were included in the study. Two leuprolide dosages were utilized for suppression: a low dose, 0.5 mg daily, and a high dose, 1 mg daily. The leuprolide dose was uniformly halved upon initiation of gonadotropin stimulation; the gonadotropin dose and preparation were identical in the two protocols. Day 3 follicle-stimulating hormone levels, duration of stimulation, amount of gonadotropins required, midcycle and peak estradiol levels, oocyte yield and implantation rates were compared. RESULTS: Lowering the dose of GnRH-a while maintaining the same stimulation protocol resulted in a faster estradiol rise and higher mean peak estradiol level. The higher estradiol levels were obtained with a lower total gonadotropin dose. The oocyte yield was not affected by the stimulation protocol utilized. CONCLUSION: Lowering the dosage of leuprolide allows higher estradiol levels in those patients. This suggests an inhibitory in vivo effect of leuprolide acetate on ovarian steroidogenesis.

Original languageEnglish (US)
Pages (from-to)413-417
Number of pages5
JournalJournal of Reproductive Medicine for the Obstetrician and Gynecologist
Volume43
Issue number5
StatePublished - May 1 1998

Fingerprint

Leuprolide
Estradiol
Gonadotropins
Fertilization in Vitro
Ovulation Induction
Gonadotropin-Releasing Hormone
Oocytes
Corpus Luteum
Follicle Stimulating Hormone
Databases

Keywords

  • Estradiol
  • Leuprolide
  • Ovary

Cite this

Kowalik, A., Barmat, L., Damario, M., Liu, H. C., Davis, O., & Rosenwaks, Z. (1998). Ovarian estradiol production in vivo inhibitory: Effect of leuprolide acetate. Journal of Reproductive Medicine for the Obstetrician and Gynecologist, 43(5), 413-417.

Ovarian estradiol production in vivo inhibitory : Effect of leuprolide acetate. / Kowalik, Ania; Barmat, Larry; Damario, Mark; Liu, Hung Ching; Davis, Owen; Rosenwaks, Zev.

In: Journal of Reproductive Medicine for the Obstetrician and Gynecologist, Vol. 43, No. 5, 01.05.1998, p. 413-417.

Research output: Contribution to journalArticle

Kowalik, A, Barmat, L, Damario, M, Liu, HC, Davis, O & Rosenwaks, Z 1998, 'Ovarian estradiol production in vivo inhibitory: Effect of leuprolide acetate', Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 43, no. 5, pp. 413-417.
Kowalik, Ania ; Barmat, Larry ; Damario, Mark ; Liu, Hung Ching ; Davis, Owen ; Rosenwaks, Zev. / Ovarian estradiol production in vivo inhibitory : Effect of leuprolide acetate. In: Journal of Reproductive Medicine for the Obstetrician and Gynecologist. 1998 ; Vol. 43, No. 5. pp. 413-417.
@article{8bccd8761b1a4bea8021f9ee93e1de74,
title = "Ovarian estradiol production in vivo inhibitory: Effect of leuprolide acetate",
abstract = "OBJECTIVE: To determine the impact of reducing the dose of gonadotropin- releasing hormone agonist (GnRH-a) for controlled ovarian stimulation in vitro fertilization (IVF) on subsequent response to stimulation and cycle outcome. STUDY DESIGN: An IVF database was searched to identify patients who underwent at least two cycles of ovarian stimulation at a university-based medical center, and a retrospective chart review was performed. Fifty-one patients whose IVF stimulation protocols during the two cycles were identical except for the leuprolide dosage utilized for luteal pituitary suppression were included in the study. Two leuprolide dosages were utilized for suppression: a low dose, 0.5 mg daily, and a high dose, 1 mg daily. The leuprolide dose was uniformly halved upon initiation of gonadotropin stimulation; the gonadotropin dose and preparation were identical in the two protocols. Day 3 follicle-stimulating hormone levels, duration of stimulation, amount of gonadotropins required, midcycle and peak estradiol levels, oocyte yield and implantation rates were compared. RESULTS: Lowering the dose of GnRH-a while maintaining the same stimulation protocol resulted in a faster estradiol rise and higher mean peak estradiol level. The higher estradiol levels were obtained with a lower total gonadotropin dose. The oocyte yield was not affected by the stimulation protocol utilized. CONCLUSION: Lowering the dosage of leuprolide allows higher estradiol levels in those patients. This suggests an inhibitory in vivo effect of leuprolide acetate on ovarian steroidogenesis.",
keywords = "Estradiol, Leuprolide, Ovary",
author = "Ania Kowalik and Larry Barmat and Mark Damario and Liu, {Hung Ching} and Owen Davis and Zev Rosenwaks",
year = "1998",
month = "5",
day = "1",
language = "English (US)",
volume = "43",
pages = "413--417",
journal = "The Journal of reproductive medicine",
issn = "0024-7758",
publisher = "Donna Kessel",
number = "5",

}

TY - JOUR

T1 - Ovarian estradiol production in vivo inhibitory

T2 - Effect of leuprolide acetate

AU - Kowalik, Ania

AU - Barmat, Larry

AU - Damario, Mark

AU - Liu, Hung Ching

AU - Davis, Owen

AU - Rosenwaks, Zev

PY - 1998/5/1

Y1 - 1998/5/1

N2 - OBJECTIVE: To determine the impact of reducing the dose of gonadotropin- releasing hormone agonist (GnRH-a) for controlled ovarian stimulation in vitro fertilization (IVF) on subsequent response to stimulation and cycle outcome. STUDY DESIGN: An IVF database was searched to identify patients who underwent at least two cycles of ovarian stimulation at a university-based medical center, and a retrospective chart review was performed. Fifty-one patients whose IVF stimulation protocols during the two cycles were identical except for the leuprolide dosage utilized for luteal pituitary suppression were included in the study. Two leuprolide dosages were utilized for suppression: a low dose, 0.5 mg daily, and a high dose, 1 mg daily. The leuprolide dose was uniformly halved upon initiation of gonadotropin stimulation; the gonadotropin dose and preparation were identical in the two protocols. Day 3 follicle-stimulating hormone levels, duration of stimulation, amount of gonadotropins required, midcycle and peak estradiol levels, oocyte yield and implantation rates were compared. RESULTS: Lowering the dose of GnRH-a while maintaining the same stimulation protocol resulted in a faster estradiol rise and higher mean peak estradiol level. The higher estradiol levels were obtained with a lower total gonadotropin dose. The oocyte yield was not affected by the stimulation protocol utilized. CONCLUSION: Lowering the dosage of leuprolide allows higher estradiol levels in those patients. This suggests an inhibitory in vivo effect of leuprolide acetate on ovarian steroidogenesis.

AB - OBJECTIVE: To determine the impact of reducing the dose of gonadotropin- releasing hormone agonist (GnRH-a) for controlled ovarian stimulation in vitro fertilization (IVF) on subsequent response to stimulation and cycle outcome. STUDY DESIGN: An IVF database was searched to identify patients who underwent at least two cycles of ovarian stimulation at a university-based medical center, and a retrospective chart review was performed. Fifty-one patients whose IVF stimulation protocols during the two cycles were identical except for the leuprolide dosage utilized for luteal pituitary suppression were included in the study. Two leuprolide dosages were utilized for suppression: a low dose, 0.5 mg daily, and a high dose, 1 mg daily. The leuprolide dose was uniformly halved upon initiation of gonadotropin stimulation; the gonadotropin dose and preparation were identical in the two protocols. Day 3 follicle-stimulating hormone levels, duration of stimulation, amount of gonadotropins required, midcycle and peak estradiol levels, oocyte yield and implantation rates were compared. RESULTS: Lowering the dose of GnRH-a while maintaining the same stimulation protocol resulted in a faster estradiol rise and higher mean peak estradiol level. The higher estradiol levels were obtained with a lower total gonadotropin dose. The oocyte yield was not affected by the stimulation protocol utilized. CONCLUSION: Lowering the dosage of leuprolide allows higher estradiol levels in those patients. This suggests an inhibitory in vivo effect of leuprolide acetate on ovarian steroidogenesis.

KW - Estradiol

KW - Leuprolide

KW - Ovary

UR - http://www.scopus.com/inward/record.url?scp=0031750832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031750832&partnerID=8YFLogxK

M3 - Article

C2 - 9610463

AN - SCOPUS:0031750832

VL - 43

SP - 413

EP - 417

JO - The Journal of reproductive medicine

JF - The Journal of reproductive medicine

SN - 0024-7758

IS - 5

ER -